Venous and arterial thrombosis in COVID-19: An updated narrative review

Venous and arterial thrombosis in COVID-19: An updated narrative review

Hospitalized patients with coronavirus disease 2019 (COVID-19), particularly those admitted to the intensive care unit (ICU) are at high risk of morbidity and mortality. Several observational studies have described hemostatic derangements and thrombotic complications in patients with COVID-19. The a...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Zainab Al Duhailib, Simon Oczkowski, Kamil Polok, Jakub Fronczek, Wojciech Szczeklik, Joshua Piticaru, Manoj J. Mammen, Fayez Alshamsi, John Eikelboom, Emilie Belley-Cote, Waleed Alhazzani
Formato:	Artigo
Idioma:	English
Publicado em:	Elsevier 2022-06-01
coleção:	Journal of Infection and Public Health
Assuntos:	Anticoagulation COVID-19 Thrombosis Venous thromboembolism prophylaxis Critically ill D-dimer level
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S187603412200123X

Registros relacionados

Risk Factors and Clinical Significance of D-Dimer in the Development of Postoperative Venous Thrombosis in Patients with Lung Tumor
por: Wang P, et al.
Publicado em: (2020-06-01)

Increased Prevalence of Elevated D-Dimer Levels in Patients on Direct Oral Anticoagulants: Results of a Large Retrospective Study
por: Sara Reda, et al.
Publicado em: (2022-03-01)

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results
por: Gualtiero Palareti, et al.
Publicado em: (2022-03-01)

Optimal duration of anticoagulant therapy in patients with venous thromboembolism
por: Gualtiero Palareti
Publicado em: (2018-09-01)

A Systematic Review on the Use of Aspirin in the Prevention of Deep Vein Thrombosis in Major Elective Lower Limb Orthopedic Surgery: An Update from the Past 3 Years
por: Dylan A. Mistry, et al.
Publicado em: (2017-10-01)

Thromboembolism in Arthroplasty: Compliance to Prophylaxis
por: Leandra Marla Aires Travassos Viana, et al.
Publicado em: (2021-12-01)

Venous thromboembolism in COVID 19 infection: Prevalence and practice of prophylaxis - A narrative
por: U Vasudeva Rao, et al.
Publicado em: (2021-01-01)

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database
por: Miguel Pisani, et al.
Publicado em: (2022-10-01)

Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement
por: Alpesh N. Amin, et al.
Publicado em: (2011-09-01)

Renal Vein Thrombosis in Idiopathic Thrombocytopenic Purpura
por: Subodh Kumar Das, et al.
Publicado em: (2020-03-01)

Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis
por: Ciuculete Denisa-Corina, et al.
Publicado em: (2021-09-01)

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider
por: Daria Solari, et al.
Publicado em: (2021-01-01)

Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery
por: Taishi Hata, et al.
Publicado em: (2019-09-01)

New knowledge of prophylaxis and treatment about cancer-associated thrombosis
por: DING Yongjie, ZHANG Liu, LI Qingyun
Publicado em: (2023-08-01)

Cancer and Thrombosis: New Treatments, New Challenges
por: Anders Erik Astrup Dahm
Publicado em: (2021-06-01)

Risk factors for Venous Thromboembolism and clinical outcomes in adults with sickle cell disease
por: Brittany Scarpato, et al.
Publicado em: (2022-03-01)

The importance of D-dimer test in the follow up of patients with deep venous thrombosis
por: Meral Ekim, et al.
Publicado em: (2018-07-01)

CONTINUOUS THROMBOPROPHYLAXIS DURING SURGICAL TREATMENT OF PATIENT WITH POLYTRAUMA IN A MULTIDISCIPLINARY HOSPITAL (CASE REPORT)
por: I. G. Belenky, et al.
Publicado em: (2017-07-01)

Equivalent VTE rates after total joint arthroplasty using thromboprophylaxis with aspirin versus potent anticoagulants: retrospective analysis of 4562 cases across a diverse healthcare system
por: Chelsea Matzko, et al.
Publicado em: (2021-12-01)

PULMONARY EMBOLISM IN BREAST CANCER: ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT APPROACHES
por: I. D. Rozanov, et al.
Publicado em: (2017-01-01)

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series
por: Nicholas L.J. Chornenki, et al.
Publicado em: (2024-08-01)

Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey
por: Hope P. Wilson, et al.
Publicado em: (2022-03-01)

Consensus document on anticoagulant management of deep vein thrombosis: A review
por: V S Bedi, et al.
Publicado em: (2021-01-01)

Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
por: Peter W. Ketch, et al.
Publicado em: (2024-12-01)

ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST
por: Samir Arnaout, et al.
Publicado em: (2011-05-01)

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
por: Hyeon-Jeong Lee, et al.
Publicado em: (2023-05-01)

Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
por: Marcello Di Nisio, et al.
Publicado em: (2024-05-01)

Deep vein thrombosis - the review
por: Karol Stępniak, et al.
Publicado em: (2024-11-01)

Cancer-Associated Thrombosis: A New Light on an Old Story
por: Sidrah Shah, et al.
Publicado em: (2021-05-01)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
por: Sven R. Olson, et al.
Publicado em: (2019-07-01)

New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
por: Mehrie H. Patel, et al.
Publicado em: (2024-05-01)

Cerebral vein thrombosis as the initial presentation of acute promyelocytic leukemia (APML)
por: Fizza Zulfiqar, et al.
Publicado em: (2025-01-01)

Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study
por: Fleur H.J. Kaptein, et al.
Publicado em: (2024-01-01)

Preoperative prevalence of deep vein thrombosis in patients scheduled to have surgery for degenerative musculoskeletal disorders
por: Keigo Sato, et al.
Publicado em: (2021-06-01)

Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
por: Philip L. Mar, MD, PharmD, et al.
Publicado em: (2020-03-01)

Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy
por: Roberts JC, et al.
Publicado em: (2022-10-01)

Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety
por: W. Anthony Hawkins, et al.
Publicado em: (2021-10-01)

D-dimer: a useful tool in gauging optimal duration of oral anticoagulant therapy?
por: M. Silingardi, et al.
Publicado em: (2013-05-01)

An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study
por: Fumihiro Ogawa, et al.
Publicado em: (2021-04-01)

Prevalence, Risk Factors of Deep Venous Thrombosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Cross-sectional Study
por: P SPURTHY, et al.
Publicado em: (2024-01-01)